Useful Instruments for Psoriasis Patients’ Follow‐Up in Teleconsultation Setting
Open Access
- 18 November 2025
- journal article
- Published by Wiley in JEADV Clinical Practice
- Vol. 5 (1) , 188-193
Abstract
Background: Teledermatology may be beneficial for psoriasis management and a working group of the International Psoriasis Council recently outlined the value of patient questionnaires in teledermatology. Objectives: Identify instruments that could optimise psoriasis evaluation when completed before a teleconsultation; assess patients’ and dermatologists’ opinions on the value of teleconsultations for managing psoriasis. Methods: This pilot, cross‐sectional study, conducted in France (November 2021 to February 2022), invited patients with psoriasis and dermatologists experienced in treating psoriasis to complete an electronic survey assessing (1) the value of teleconsultations, (2) the attributes of 12 specific instruments to be used in teleconsultation, and (3) the most important attributes of these instruments. The specific instruments assessed covered three domains: (1) Quality of life (QoL; Dermatology Life Quality Index [DLQI] and SKINDEX), (2) disease severity and involvement (Simplified Psoriasis Index [Sa‐SPI]; self‐evaluations of pruritus, pain and severity on a numeric rating scale [NRS]; self‐evaluations of involved body surface area [BSA]; skin photography), (3) rheumatology (Psoriatic Arthritis Uncluttered Screening Evaluation [PURE], Early ARthritis for Psoriatic patients [EARP], Psoriasis Epidemiology Screening Tool [PEST]). Results: From 100 patients responding, 75 were willing to be followed in a telemedicine setting. The instrument attributes most important to patients were helping overcome teleconsultation limitations and facilitating conversations. From 51 dermatologists responding, 42 were in favour of telemedicine. The instrument attributes most important to dermatologists were clinical relevance and helping overcome teleconsultation limitations. Patients and dermatologists ranked the tools similarly, with DLQI scoring higher than SKINDEX, and Sa‐SPI scoring higher than self‐evaluations of pruritus, pain and severity, self‐evaluations of involved BSA and skin photography. There was no preferred rheumatology questionnaire. Conclusions: Our data suggest DLQI, Sa‐SPI, and a rheumatology questionnaire could be useful to complete and transmit before a dermatology teleconsultation. These findings should be validated in a larger study with global participants.Keywords
This publication has 13 references indexed in Scilit:
- Telemedicine and psoriasis: A review based on statements of the telemedicine working group of the International Psoriasis CouncilJEADV Clinical Practice, 2022
- Teledermatology: current indications and considerations for future useArchives of Dermatological Research, 2020
- French guidelines on the use of systemic treatments for moderate‐to‐severe psoriasis in adultsJournal of the European Academy of Dermatology and Venereology, 2019
- Psoriatic arthritis screening by the dermatologist: development and first validation of the ‘PURE‐4 scale’Journal of the European Academy of Dermatology and Venereology, 2018
- The Simplified Psoriasis Index (SPI): A Practical Tool for Assessing PsoriasisJournal of Investigative Dermatology, 2013
- The early psoriatic arthritis screening questionnaire: a simple and fast method for the identification of arthritis in patients with psoriasisRheumatology, 2012
- The Skindex Instruments to Measure the Effects of Skin Disease on Quality of LifeDermatologic Clinics, 2012
- Reliability, validity and responsiveness to change of the Patient Report of Extent of Psoriasis Involvement (PREPI) for measuring body surface area affected by psoriasisBritish Journal of Dermatology, 2009
- Quality of life assessments in dermatologySeminars in Cutaneous Medicine and Surgery, 1998
- The outcomes movement and new measures of the severity of psoriasisJournal of the American Academy of Dermatology, 1996